These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9683791)

  • 1. Sequential overexpression of LRP and MRP but not P-gp 170 in VP16-selected A549 adenocarcinoma cells.
    Trussardi A; Poitevin G; Gorisse MC; Faroux MJ; Bobichon H; Delvincourt C; Jardillier JC
    Int J Oncol; 1998 Sep; 13(3):543-8. PubMed ID: 9683791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines.
    Lee E; Lim SJ
    Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
    Stein U; Walther W; Laurencot CM; Scheffer GL; Scheper RJ; Shoemaker RH
    J Natl Cancer Inst; 1997 Jun; 89(11):807-13. PubMed ID: 9182980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
    Uchiyama-Kokubu N; Watanabe T
    Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].
    Peng ZM; Luo J; Wang WB; Wang XH; Chen JH; Lan SM
    Ai Zheng; 2004 Aug; 23(8):963-7. PubMed ID: 15301725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):304-7. PubMed ID: 11778556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines.
    Laurençot CM; Scheffer GL; Scheper RJ; Shoemaker RH
    Int J Cancer; 1997 Sep; 72(6):1021-6. PubMed ID: 9378536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
    Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
    Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance-related transporters in human breast carcinoma.
    Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues.
    Dingemans AM; van Ark-Otte J; van der Valk P; Apolinario RM; Scheper RJ; Postmus PE; Giaccone G
    Ann Oncol; 1996 Aug; 7(6):625-30. PubMed ID: 8879378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
    Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
    Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
    Ax W; Soldan M; Koch L; Maser E
    Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
    Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
    Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.
    Alexander D; Yamamoto T; Kato S; Kasai S
    Surg Today; 1999; 29(5):401-6. PubMed ID: 10333409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.